Citigroup issued new guidance showing it would take the lender more time to catch up to Wall Street peers than some investors hoped for. Sridhar Natarajan reports on Bloomberg Television. (Source: Bloomberg)
Citigroup issued new guidance showing it would take the lender more time to catch up to Wall Street peers than some investors hoped for. Sridhar Natarajan reports on Bloomberg Television. (Source: Bloomberg)
At least 29 passengers of 12 nationalities left the MV Hondius on 24 April after the first fatality Where did the cruise ship hantavirus come from and what happens next? Europe live – latest updates Authorities around the world are racing to trace dozens of passengers who disembarked from the cruise ship at the centre of a deadly hantavirus outbreak before isolation measures were implemented. It e...
At least 29 passengers of 12 nationalities left the MV Hondius on 24 April after the first fatality Where did the cruise ship hantavirus come from and what happens next? Europe live – latest updates Authorities around the world are racing to trace dozens of passengers who disembarked from the cruise ship at the centre of a deadly hantavirus outbreak before isolation measures were implemented. It emerged for the first time on Thursday that at least 29 passengers of 12 nationalities left the MV Hondius on 24 April after the first fatality, prompting a scramble to identify and track their movements since then. Continue reading...
Minerva S.A. ( MRVSY ): Q1 net income of R$87.3M Gross revenue of R$14.48B (+21.4% Y/Y). Net revenue of R$13.4B. EBITDA reached R$1.1B in 1Q26, with an EBITDA margin of 8.3%, up by 16.2% over 1Q25. Over the last twelve months, EBITDA totaled R$5B, a record for the 12-month period, with a margin of 8.7%. More on Minerva S.A. Historical earnings data for Minerva S.A. Dividend scorecard for Minerva S...
Minerva S.A. ( MRVSY ): Q1 net income of R$87.3M Gross revenue of R$14.48B (+21.4% Y/Y). Net revenue of R$13.4B. EBITDA reached R$1.1B in 1Q26, with an EBITDA margin of 8.3%, up by 16.2% over 1Q25. Over the last twelve months, EBITDA totaled R$5B, a record for the 12-month period, with a margin of 8.7%. More on Minerva S.A. Historical earnings data for Minerva S.A. Dividend scorecard for Minerva S.A. Financial information for Minerva S.A.
The leaders of Thailand and Cambodia agreed on Thursday to pursue trust-building measures to advance a fragile ceasefire and establish peace, after rare talks over last year’s deadly fighting between the two neighbours. Troops remain deployed on both sides of their long-disputed 817km (508-mile) border after battles in July and December when skirmishes quickly escalated into air strikes and heavy...
The leaders of Thailand and Cambodia agreed on Thursday to pursue trust-building measures to advance a fragile ceasefire and establish peace, after rare talks over last year’s deadly fighting between the two neighbours. Troops remain deployed on both sides of their long-disputed 817km (508-mile) border after battles in July and December when skirmishes quickly escalated into air strikes and heavy exchanges of artillery and rockets. The Philippines, which is hosting Asean meetings on the island...
Apple stock on Thursday cleared a five-month consolidation pattern and hit a record high. In morning trades on the stock market today, Apple hit an all-time high of 292.13. In recent trades, Apple stock rose more than 1% to 290.91.
Apple stock on Thursday cleared a five-month consolidation pattern and hit a record high. In morning trades on the stock market today, Apple hit an all-time high of 292.13. In recent trades, Apple stock rose more than 1% to 290.91.
bgwalker/iStock Unreleased via Getty Images Investment Overview CVS Health Corporation ( CVS ), the U.S. healthcare giant, reported its Q1 earnings yesterday, prompting a positive reaction on Wall Street. CVS stock gained ~8% in trading, rising to a high of ~$87 per share - its highest value in over three years. Shares are now up ~10% year-to-date, ~30% on a 1-year basis, and ~4% on a five-year ba...
bgwalker/iStock Unreleased via Getty Images Investment Overview CVS Health Corporation ( CVS ), the U.S. healthcare giant, reported its Q1 earnings yesterday, prompting a positive reaction on Wall Street. CVS stock gained ~8% in trading, rising to a high of ~$87 per share - its highest value in over three years. Shares are now up ~10% year-to-date, ~30% on a 1-year basis, and ~4% on a five-year basis. On a ten-year basis, they remain down >15%. CVS earned total revenues of $100.4bn, up >6% year-on-year, and earned adjusted operating income of $5.15bn, up ~12.5% year-on-year, while GAAAP earnings per share ("EPS") increased 64% to $2.3, and adjusted EPS increased ~14%, to $2.57. Cash flow from operations amounted to $4.2bn. It was strong quarter, results comfortably exceeding analysts expectations on revenues and earnings, marking a timely reversal in fortunes for the company. Between 2023 and 2025, CVS stock typically fell sharply in response to quarterly earnings, as the company regularly missed targets, downgraded, guidance, and fired members of its senior management team. In December 2024, CVS stock sank to a low of <$45, but it has nearly doubled in value since, and upbeat guidance for 2026, shared below (source: CVS earnings presentation ) suggests the bull run can continue. CVS guidance 2026 (presentation) As we can see, CVS hiked its full-year revenue guidance upwards by $5bn, to $405bn, hiked adjusted EPS from $7.1, to $7.4, and hiked cash flow from operations by $0.5bn, to $9.5bn. Recovery Driven By The Magic Number - Medical Benefit Ratio CVS writes in its Q1 2026 quarterly report / 10-Q filing : As of March 31, 2026, the Company had approximately 9,000 retail locations, more than 1,000 walk-in and primary care medical clinics and a leading pharmacy benefits manager with approximately 88 million plan members and expanding specialty pharmacy solutions. The Company also serves an estimated more than 37 million people through a broad range of health insurance...
Shares of CPU-maker Arm Holdings are diving Thursday as concerns about its ability to meet surging chip demand overshadowed better-than-expected fiscal fourth quarter revenue and earnings . But Evercore ISI has nothing but confidence in the semiconductor designer and thinks its market value could one day surpass $1 trillion, putting it in league with other megacaps like Nvidia , Apple , Alphabet a...
Shares of CPU-maker Arm Holdings are diving Thursday as concerns about its ability to meet surging chip demand overshadowed better-than-expected fiscal fourth quarter revenue and earnings . But Evercore ISI has nothing but confidence in the semiconductor designer and thinks its market value could one day surpass $1 trillion, putting it in league with other megacaps like Nvidia , Apple , Alphabet and Microsoft . "ARM has the similar necessary ingredients to cross that $1T threshold themselves, namely that ARM is a de facto standard for rapidly emerging CPU standard in handsets, AI datacenter, IoT, auto robotics, in rapidly growing markets (agentic AI) that plays to their long suit in CPU technology," analysts Mark Lipacis and Joseph McCormack at Evercore wrote in a Thursday note to investors, referring to central processing units and the Internet of Things. A market capitalization of $1 trillion would make Cambridge, England-based Arm worth nearly five times its current value of some $209 billion, according to FactSet. The Evercore analysts see Arm's real advantage for expanding its market cap in its diverse and well-established network of suppliers and customers. They've gotten the hard part out of the way, which will allow for the easier work of ramping product, they said. "ARM has spent the last 35 years building an ecosystem and establishing themselves as the de facto standard, which we view as the most difficult steps," Evercore said, reiterating an outperform rating and raising its 12-month price target to $326 from $227. Surging demand for memory, storage and CPUs in the exploding buildout for artificial intelligence notwithstanding, concerns about component availability are serious, and they're weighing on Arm's projected $2 billion in customer demand for its debut data-center CPU. "Advanced-node wafer availability at TSMC remains the gating factor, limiting near-term confidence in Arm's ability to fully capture the potential $2bn+ FY27/28 chip opportunity," ...
EschCollection/DigitalVision via Getty Images Investment overview I wrote about Amrize AG ( AMRZ ) previously with a buy rating as I was bullish on the growth outlook, which was supported by demand for data centers, and also that AMRZ has been delivering on its cost-savings initiatives. While the segment performance in Q1 2026 looked mixed (for Q1 2026 earnings numbers, please refer to the press r...
EschCollection/DigitalVision via Getty Images Investment overview I wrote about Amrize AG ( AMRZ ) previously with a buy rating as I was bullish on the growth outlook, which was supported by demand for data centers, and also that AMRZ has been delivering on its cost-savings initiatives. While the segment performance in Q1 2026 looked mixed (for Q1 2026 earnings numbers, please refer to the press release ), I think the underlying story improved. Building Materials, or BM, is now a real growth driver, with strong volume growth and margin expansion. For commercial, demand also appears broader than I first thought, with strength seen across data centers, energy, warehousing, and logistics. Views on BM segment The main reason I stay bullish is that the Building Materials [BM] story is showing up in the numbers, but what matters even more is the quality of that strength. Note that cement pricing was relatively weak in the quarter, and yet the segment still delivered this kind of growth. In other words, the strength was not being carried by price. It was being carried by actual movement in material (i.e., organic demand). For a business like AMRZ, growing by organic volume is a lot more important because it tells us whether projects are moving. Projects moving = demand for cement/aggregates is flowing = better equipment utilization = better margin profile. For pricing, it can go up and down intra-quarter due to timing, comps, or mix. As such, it is not the best growth driver. Anyway, volume growth is a more durable signal. It also fits what AMRZ has been saying around operational efficiency and cost savings. BM margin has expanded by 230 bps in this recent quarter, so stronger demand is already turning into better economics. The way I see it, the current setup also looks more durable as management linked the growth to new project starts and multi-year supply agreements for major projects. This is huge because it suggests Q1 was not driven by one-off events. These are longe...
olrat/iStock Editorial via Getty Images Germany’s proposal to acquire a stake in Franco-German defense group KNDS is facing uncertainty due to divisions within the governing coalition, according to a report by Handelsblatt citing official documents and unnamed sources. Berlin has been exploring a pre-initial public offering investment in the tank manufacturer as a way to protect national security ...
olrat/iStock Editorial via Getty Images Germany’s proposal to acquire a stake in Franco-German defense group KNDS is facing uncertainty due to divisions within the governing coalition, according to a report by Handelsblatt citing official documents and unnamed sources. Berlin has been exploring a pre-initial public offering investment in the tank manufacturer as a way to protect national security interests and preserve influence alongside France. However, key aspects of the plan, including the size and structure of any government holding, remain unresolved. The report said the defense ministry supports a stake of roughly 40%, while the economy ministry and the chancellery favor a smaller share closer to 30%. Germany’s economy ministry declined to comment on the specifics, citing ongoing discussions with the company, but said it continues to evaluate a potential investment aimed at safeguarding critical defense technologies. KNDS did not immediately respond to requests for comment, and France’s defense ministry also declined to comment. France and KNDS are said to be moving ahead with plans for an IPO as soon as next month, leaving limited time for Berlin to finalize its position. According to the report, joining the company after the listing is not currently viewed as a viable option within the German government. More on Select STOXX Europe Aerospace & Defense ETF U.S. Defense Stock Underperformance: What The Market Is Telling Us EUAD: Europe Has No Choice, And This ETF Could Be The Big Beneficiary Germany warns of defense gap as U.S. signals possible missile pullback Australia expands military buildout with $860M vehicle purchase Seeking Alpha’s Quant Rating on Select STOXX Europe Aerospace & Defense ETF
U.S. stocks (^DJI, ^GSPC, ^IXIC) have rallied over the past three weeks, fueled by strong earnings and optimism around a potential resolution to the U.S.-Iran conflict. Yahoo Finance’s Julie Hyman and Head of News Myles Udland break down the stealth rally and spotlight some of the top names leading the tech-driven surge, including Intel (INTC), Sandisk (SNDK), Micron (MU), Seagate (STX), and Arm (...
U.S. stocks (^DJI, ^GSPC, ^IXIC) have rallied over the past three weeks, fueled by strong earnings and optimism around a potential resolution to the U.S.-Iran conflict. Yahoo Finance’s Julie Hyman and Head of News Myles Udland break down the stealth rally and spotlight some of the top names leading the tech-driven surge, including Intel (INTC), Sandisk (SNDK), Micron (MU), Seagate (STX), and Arm (ARM).